Completed Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency NCT02789332 Conditions BRCA 1 /2 and / or HRD, Breast Cancer, Breast Diseases, +8 more Locations Kliniken Esslingen, Gynäkologie Onkologie — Esslingen am Neckar, Baden-Wurttemberg, Germany Universitätsklinikum Erlangen — Erlangen, Bavaria, Germany Onkologisches Zentrum am Rotkreuzklinikum München — München, Bavaria, Germany Elisabeth Krankenhaus — Kassel, Hesse, Germany View more locations Show fewer locations Loading locations... View Trial Details
